FUCONPO Capsule Recalled for Marketing Without Approved NDA or ANDA
Murray International Trading Co. is recalling FUCONPO Capsules because they are marketed as dietary supplements but bear drug claims, making them unapproved drugs.
What this means for you
Illness, injury, or structural failure has been reported. Stop using the product immediately and contact the manufacturer for a refund or repair.
Our severity reasoning: The agency classification is FDA Class II, which corresponds to a Severe rating (score 4) per the rubric, as the product is an unapproved drug marketed with drug claims.
Plain-English summary
Murray International Trading Co., Inc. is recalling FUCONPO Capsules, which are packaged in 30-count bottles within boxes. The remaining labeling on the product contains Chinese characters. The recall covers all lots of the product.
The recall was initiated because the product is marketed without an approved New Drug Application (NDA) or Abbreviated New Drug Application (ANDA). Although the product is marked as a dietary supplement, its labeling bears drug and disease claims. This classification makes the product an unapproved drug under FDA regulations.
The product was distributed nationwide and in Puerto Rico. Consumers who have purchased FUCONPO Capsules should stop using the product and contact the recalling firm for further instructions.
The recalled product
- Product
- FUCONPO CAPSULE, packaged in a 30-count bottle within a box, remaining labeling contains Chinese characters.
- Manufacturer
- Murray International Trading Co., Inc.
- Category
- Drug — Unapproved Drug
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (1)
- All lots
Distribution
Part of a larger recall action
This product is one of 14 recalled by Murray International Trading Co., Inc. under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 14 products in this recall →Related recalls
Same manufacturer · Murray International Trading Co., Inc.
See all →- HighHerbal Doctor Angelicae Sinensis Recalled for Elevated Lead and Cadmium
FDA (Food) · 2021-12-08
- ModerateGastrodia Capsules Recalled for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Trading Recalls Farser Kai Yeung Pill for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Unapproved Flucinonide Ointment Cream
FDA (Drugs) · 2016-07-20
- ModerateMurray International Recalls Tien Ma Tou Tong Wan Pills for Unapproved Drug Claims
FDA (Drugs) · 2016-07-20
Same hazard · unapproved drug
See all →- CriticalBuy-Herbal Recalls Kian Pee Wan Capsules for Undeclared Drug Ingredients
FDA (Drugs) · 2026-08-19
- SevereMR. 7 Super capsules recalled as Class I over undeclared sildenafil
FDA (Drugs) · 2026-03-11
- SevereMojo Max Fusion capsules recalled as Class I over undeclared drug ingredients
FDA (Drugs) · 2026-03-11
- SevereSilintan herbal pills recalled as Class I for undeclared meloxicam
FDA (Drugs) · 2026-03-11
- SevereAgebox iKids-Growth Day Formula Capsules Recalled Over Undeclared Drug Ingredient
FDA (Drugs) · 2026-03-04